CareLit · DOI-Nachweis · Pneumologie
Incidence and treatment outcome of EGFR and inactivating P53 alterations in a cohort of 218 consecutively tested patients from a certified lung cancer center
DOI 10.1055/s-0035-1544762
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Griesinger, A Lüers, R Prenzel, S Douglas, KC Willborn, U Stropiep, M Falk, C Hallas, M Tiemann, F Griesinger
ZeitschriftPneumologie
Ausgabe02/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: p53 mutations are common in lung cancer, and have also been described in EGFR mutated patients. The impact of p53 mutations in EGFR mt patients is controversial, current data suggest that p53 mutations do not represent a negative prognostic marker and also are not a negative predictive factor for response to EGFR TKI. The aim of the study was therefore to systematically analyze EGFR and p53 mutations w…
Zitieren
Zitierempfehlung
F Griesinger, A Lüers, R Prenzel, S Douglas, KC Willborn, U Stropiep, M Falk, C Hallas, M Tiemann, F Griesinger (2015) Incidence and treatment outcome of EGFR and inactivating P53 alterations in a cohort of 218 consecutively tested patients from a certified lung cancer center. Pneumologie (02). https://doi.org/10.1055/s-0035-1544762
Mit CareLit weiterarbeiten